Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-02-17

Clinical Trial Update: Nasal Gel Under Military Operational Conditions for the Prevention of Nausea Associated With Motion Sickness [Phase 3]

View source ↗

Summary

Phase 3 trial update on a nasal gel intended to prevent nausea from motion sickness under military operational conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nasal Gel for Motion Sickness

Snippet

Sponsor: Repurposed Therapeutics, Inc. | Conditions: Motion Sickness | Phase 3 | Status: UNKNOWN